Year |
Citation |
Score |
2020 |
Salvadore G, Bonaventure P, Shekhar A, Johnson PL, Lord B, Shireman BT, Lebold TP, Nepomuceno D, Dugovic C, Brooks S, Zuiker R, Bleys C, Tatikola K, Remmerie B, Jacobs GE, et al. Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans. Translational Psychiatry. 10: 308. PMID 32895369 DOI: 10.1038/S41398-020-00937-9 |
0.344 |
|
2020 |
Bernabe CS, Caliman IF, Truitt WA, Molosh AI, Lowry CA, Hay-Schmidt A, Shekhar A, Johnson PL. Using loss- and gain-of-function approaches to target amygdala-projecting serotonergic neurons in the dorsal raphe nucleus that enhance anxiety-related and conditioned fear behaviors. Journal of Psychopharmacology (Oxford, England). 269881119900981. PMID 32153226 DOI: 10.1177/0269881119900981 |
0.326 |
|
2020 |
Patel J, Dustrude E, Haulcomb M, Li L, Jiang G, Liu Y, Lai Y, Molosh A, Shekhar A. Role of PSD95 and nNOS Interaction in Gene Regulation following Fear Conditioning and Implications for Molecular Mechanisms Underlying Post-Traumatic Stress Disorder Biological Psychiatry. 87: S334. DOI: 10.1016/J.Biopsych.2020.02.858 |
0.307 |
|
2019 |
Niculescu AB, Le-Niculescu H, Roseberry K, Wang S, Hart J, Kaur A, Robertson H, Jones T, Strasburger A, Williams A, Kurian SM, Lamb B, Shekhar A, Lahiri DK, Saykin AJ. Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs. Molecular Psychiatry. PMID 31792364 DOI: 10.1038/S41380-019-0602-2 |
0.31 |
|
2019 |
Shekhar A. Role of Kappa Opioid Receptors in Symptoms of Schizophrenia: What Is the Neurobiology? Biological Psychiatry. 86: 494-496. PMID 31521206 DOI: 10.1016/J.Biopsych.2019.08.004 |
0.302 |
|
2019 |
Donner NC, Mani S, Fitz SD, Kienzle DM, Shekhar A, Lowry CA. Crh receptor priming in the bed nucleus of the stria terminalis induces tph2 gene expression in the dorsomedial dorsal raphe nucleus and chronic anxiety. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109730. PMID 31415826 DOI: 10.1016/J.Pnpbp.2019.109730 |
0.332 |
|
2019 |
Johnson PL, Molosh AI, Federici LM, Bernabe C, Haggerty D, Fitz SD, Nalivaiko E, Truitt W, Shekhar A. Assessment of fear and anxiety associated behaviors, physiology and neural circuits in rats with reduced serotonin transporter (SERT) levels. Translational Psychiatry. 9: 33. PMID 30670681 DOI: 10.1038/S41398-019-0368-Y |
0.771 |
|
2019 |
Molosh A, Dustrude E, Lukkes J, Truitt W, Bhatnagar S, Donck Lv, Kent J, Ceusters M, Bonaventure P, Johnson P, Shekhar A. 74. Mechanisms of Agoraphobia: Contribution of Orexin and mGluR2 Signaling in the Amygdala Biological Psychiatry. 85: S30-S31. DOI: 10.1016/J.Biopsych.2019.03.088 |
0.66 |
|
2018 |
Dustrude ET, Caliman IF, Bernabe CS, Fitz SD, Grafe LA, Bhatnagar S, Bonaventure P, Johnson PL, Molosh AI, Shekhar A. Orexin Depolarizes Central Amygdala Neurons via Orexin Receptor 1, Phospholipase C and Sodium-Calcium Exchanger and Modulates Conditioned Fear. Frontiers in Neuroscience. 12: 934. PMID 30618563 DOI: 10.3389/Fnins.2018.00934 |
0.307 |
|
2018 |
Molosh AI, Shekhar A. Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms. Progress in Brain Research. 241: 37-62. PMID 30447756 DOI: 10.1016/Bs.Pbr.2018.09.014 |
0.322 |
|
2018 |
Drozd HP, Karathanasis SF, Molosh AI, Lukkes JL, Clapp DW, Shekhar A. From bedside to bench and back: Translating ASD models. Progress in Brain Research. 241: 113-158. PMID 30447753 DOI: 10.1016/Bs.Pbr.2018.10.003 |
0.696 |
|
2018 |
Patel J, Lukkes JL, Shekhar A. Overview of genetic models of autism spectrum disorders. Progress in Brain Research. 241: 1-36. PMID 30447752 DOI: 10.1016/Bs.Pbr.2018.10.002 |
0.706 |
|
2018 |
Shekhar A, Thakur GA. Cannabinoid Receptor 1 Positive Allosteric Modulators for Posttraumatic Stress Disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 43: 226-227. PMID 29192662 DOI: 10.1038/Npp.2017.230 |
0.307 |
|
2017 |
Niculescu AB, Le-Niculescu H, Levey DF, Phalen PL, Dainton HL, Roseberry K, Niculescu EM, Niezer JO, Williams A, Graham DL, Jones TJ, Venugopal V, Ballew A, Yard M, Gelbart T, ... ... Shekhar A, et al. Precision medicine for suicidality: from universality to subtypes and personalization. Molecular Psychiatry. PMID 28809398 DOI: 10.1038/Mp.2017.128 |
0.314 |
|
2017 |
Forster SE, Zirnheld P, Shekhar A, Steinhauer SR, O'Donnell BF, Hetrick WP. Event-related potentials reflect impaired temporal interval learning following haloperidol administration. Psychopharmacology. PMID 28601965 DOI: 10.1007/S00213-017-4645-2 |
0.654 |
|
2017 |
Lukkes JL, Molosh AI, Shekhar A. Sex-dependent effects of adolescent social stress on depressive behavior and stress-related neurocircuitry Psychoneuroendocrinology. 83: 88. DOI: 10.1016/J.Psyneuen.2017.07.476 |
0.664 |
|
2015 |
Johnson PL, Molosh A, Fitz SD, Arendt D, Deehan GA, Federici LM, Bernabe C, Engleman EA, Rodd ZA, Lowry CA, Shekhar A. Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning. Pharmacology, Biochemistry, and Behavior. 138: 174-9. PMID 26476009 DOI: 10.1016/J.Pbb.2015.09.021 |
0.317 |
|
2015 |
Goddard AW, Mahmud W, Medlock C, Shin YW, Shekhar A. A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder. Annals of General Psychiatry. 14: 26. PMID 26379759 DOI: 10.1186/S12991-015-0064-0 |
0.319 |
|
2015 |
Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N, Belanger E, James A, George S, Weber H, Graham DL, Schweitzer R, Ladd TB, Learman R, Niculescu EM, ... ... Shekhar A, et al. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Molecular Psychiatry. PMID 26283638 DOI: 10.1038/Mp.2015.112 |
0.313 |
|
2015 |
Bonaventure P, Yun S, Johnson PL, Shekhar A, Fitz SD, Shireman BT, Lebold TP, Nepomuceno D, Lord B, Wennerholm M, Shelton J, Carruthers N, Lovenberg T, Dugovic C. A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects. The Journal of Pharmacology and Experimental Therapeutics. 352: 590-601. PMID 25583879 DOI: 10.1124/Jpet.114.220392 |
0.303 |
|
2014 |
Johnson PL, Federici LM, Shekhar A. Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks. Neuroscience and Biobehavioral Reviews. 46: 429-54. PMID 25130976 DOI: 10.1016/J.Neubiorev.2014.07.027 |
0.305 |
|
2014 |
Shekhar A. Angiotensin type 1 receptor antagonists-a novel approach to augmenting posttraumatic stress disorder and phobia therapies? Biological Psychiatry. 75: 836-7. PMID 24837620 DOI: 10.1016/J.Biopsych.2014.04.004 |
0.337 |
|
2014 |
Paul ED, Johnson PL, Shekhar A, Lowry CA. The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic. Neuroscience and Biobehavioral Reviews. 46: 379-96. PMID 24661986 DOI: 10.1016/J.Neubiorev.2014.03.010 |
0.341 |
|
2014 |
Lungwitz EA, Stuber GD, Johnson PL, Dietrich AD, Schartz N, Hanrahan B, Shekhar A, Truitt WA. The role of the medial prefrontal cortex in regulating social familiarity-induced anxiolysis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1009-19. PMID 24157502 DOI: 10.1038/Npp.2013.302 |
0.308 |
|
2013 |
Le-Niculescu H, Levey DF, Ayalew M, Palmer L, Gavrin LM, Jain N, Winiger E, Bhosrekar S, Shankar G, Radel M, Bellanger E, Duckworth H, Olesek K, Vergo J, Schweitzer R, ... ... Shekhar A, et al. Discovery and validation of blood biomarkers for suicidality. Molecular Psychiatry. 18: 1249-64. PMID 23958961 DOI: 10.1038/Mp.2013.95 |
0.322 |
|
2013 |
Johannesen JK, O'Donnell BF, Shekhar A, McGrew JH, Hetrick WP. Diagnostic specificity of neurophysiological endophenotypes in schizophrenia and bipolar disorder. Schizophrenia Bulletin. 39: 1219-29. PMID 22927673 DOI: 10.1093/Schbul/Sbs093 |
0.697 |
|
2012 |
Lungwitz EA, Molosh A, Johnson PL, Harvey BP, Dirks RC, Dietrich A, Minick P, Shekhar A, Truitt WA. Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiology & Behavior. 107: 726-32. PMID 22652097 DOI: 10.1016/J.Physbeh.2012.05.019 |
0.314 |
|
2012 |
Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger JI, Corvin A, Geyer M, Tsuang MT, et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Molecular Psychiatry. 17: 887-905. PMID 22584867 DOI: 10.1038/Mp.2012.37 |
0.383 |
|
2012 |
Johnson PL, Samuels BC, Fitz SD, Federici LM, Hammes N, Early MC, Truitt W, Lowry CA, Shekhar A. Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiology & Behavior. 107: 733-42. PMID 22554617 DOI: 10.1016/J.Physbeh.2012.04.016 |
0.363 |
|
2012 |
Hale MW, Shekhar A, Lowry CA. Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. Cellular and Molecular Neurobiology. 32: 695-708. PMID 22484834 DOI: 10.1007/S10571-012-9827-1 |
0.328 |
|
2012 |
Johnson PL, Shekhar A. An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus. Physiology & Behavior. 107: 686-98. PMID 22484112 DOI: 10.1016/J.Physbeh.2012.03.016 |
0.391 |
|
2012 |
Johnson PL, Samuels BC, Fitz SD, Lightman SL, Lowry CA, Shekhar A. Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1911-22. PMID 22453138 DOI: 10.1038/Npp.2012.38 |
0.324 |
|
2012 |
Bolbecker AR, Shekhar A. Muscarinic agonists and antagonists in schizophrenia: recent therapeutic advances and future directions. Handbook of Experimental Pharmacology. 167-90. PMID 22222699 DOI: 10.1007/978-3-642-23274-9_8 |
0.367 |
|
2011 |
Le-Niculescu H, Balaraman Y, Patel SD, Ayalew M, Gupta J, Kuczenski R, Shekhar A, Schork N, Geyer MA, Niculescu AB. Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms. Translational Psychiatry. 1: e9. PMID 22832404 DOI: 10.1038/Tp.2011.9 |
0.4 |
|
2011 |
Snyder AN, Bockbrader MA, Hoffa AM, Dzemidzic MA, Talavage TM, Wong D, Lowe MJ, O'Donnell BF, Shekhar A. Psychometrically matched tasks evaluating differential fMRI activation during form and motion processing. Neuropsychology. 25: 622-33. PMID 21534685 DOI: 10.1037/A0022984 |
0.528 |
|
2011 |
Lukkes JL, Staub DR, Dietrich A, Truitt W, Neufeld-Cohen A, Chen A, Johnson PL, Shekhar A, Lowry CA. Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylase. Neuroscience. 183: 47-63. PMID 21453754 DOI: 10.1016/J.Neuroscience.2011.03.047 |
0.672 |
|
2011 |
Shekhar A, Johnson PL, Fitz SD, Nakazato A, Chaki S, Steckler T, Schmidt M. A selective, non-peptide CRF receptor 1 antagonist prevents sodium lactate-induced acute panic-like responses. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 355-65. PMID 21087553 DOI: 10.1017/S1461145710001355 |
0.355 |
|
2010 |
Rass O, Krishnan G, Brenner CA, Hetrick WP, Merrill CC, Shekhar A, O'Donnell BF. Auditory steady state response in bipolar disorder: relation to clinical state, cognitive performance, medication status, and substance disorders. Bipolar Disorders. 12: 793-803. PMID 21176026 DOI: 10.1111/J.1399-5618.2010.00871.X |
0.707 |
|
2010 |
Shin YW, Krishnan G, Hetrick WP, Brenner CA, Shekhar A, Malloy FW, O'Donnell BF. Increased temporal variability of auditory event-related potentials in schizophrenia and Schizotypal Personality Disorder. Schizophrenia Research. 124: 110-8. PMID 20817485 DOI: 10.1016/J.Schres.2010.08.008 |
0.712 |
|
2010 |
Coric V, Feldman HH, Oren DA, Shekhar A, Pultz J, Dockens RC, Wu X, Gentile KA, Huang SP, Emison E, Delmonte T, D'Souza BB, Zimbroff DL, Grebb JA, Goddard AW, et al. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depression and Anxiety. 27: 417-25. PMID 20455246 DOI: 10.1002/Da.20695 |
0.302 |
|
2010 |
Molosh AI, Johnson PL, Fitz SD, Dimicco JA, Herman JP, Shekhar A. Changes in central sodium and not osmolarity or lactate induce panic-like responses in a model of panic disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1333-47. PMID 20130534 DOI: 10.1038/Npp.2010.2 |
0.374 |
|
2010 |
Goddard AW, Ball SG, Martinez J, Robinson MJ, Yang CR, Russell JM, Shekhar A. Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depression and Anxiety. 27: 339-50. PMID 19960531 DOI: 10.1002/Da.20642 |
0.306 |
|
2010 |
Chambers RA, Sentir AM, Conroy SK, Truitt WA, Shekhar A. Cortical-striatal integration of cocaine history and prefrontal dysfunction in animal modeling of dual diagnosis. Biological Psychiatry. 67: 788-92. PMID 19880093 DOI: 10.1016/J.Biopsych.2009.09.006 |
0.326 |
|
2009 |
Fridberg DJ, Hetrick WP, Brenner CA, Shekhar A, Steffen AN, Malloy FW, O'Donnell BF. Relationships between auditory event-related potentials and mood state, medication, and comorbid psychiatric illness in patients with bipolar disorder. Bipolar Disorders. 11: 857-66. PMID 19922554 DOI: 10.1111/J.1399-5618.2009.00758.X |
0.698 |
|
2009 |
Carroll CA, O'Donnell BF, Shekhar A, Hetrick WP. Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task. Brain and Cognition. 71: 345-53. PMID 19664870 DOI: 10.1016/J.Bandc.2009.06.009 |
0.699 |
|
2009 |
Brenner CA, Kieffaber PD, Clementz BA, Johannesen JK, Shekhar A, O'Donnell BF, Hetrick WP. Event-related potential abnormalities in schizophrenia: a failure to "gate in" salient information? Schizophrenia Research. 113: 332-8. PMID 19628376 DOI: 10.1016/J.Schres.2009.06.012 |
0.696 |
|
2009 |
Krishnan GP, Hetrick WP, Brenner CA, Shekhar A, Steffen AN, O'Donnell BF. Steady state and induced auditory gamma deficits in schizophrenia. Neuroimage. 47: 1711-9. PMID 19371786 DOI: 10.1016/J.Neuroimage.2009.03.085 |
0.683 |
|
2009 |
Carroll CA, O'Donnell BF, Shekhar A, Hetrick WP. Timing dysfunctions in schizophrenia span from millisecond to several-second durations. Brain and Cognition. 70: 181-90. PMID 19282082 DOI: 10.1016/J.Bandc.2009.02.001 |
0.696 |
|
2009 |
Bolbecker AR, Hetrick WP, Johannesen JK, O'Donnell BF, Steinmetz JE, Shekhar AS. Secretin effects on cerebellar-dependent motor learning in schizophrenia. The American Journal of Psychiatry. 166: 460-6. PMID 19223439 DOI: 10.1176/Appi.Ajp.2008.08040597 |
0.664 |
|
2009 |
Bolbecker AR, Mehta C, Johannesen JK, Edwards CR, O'Donnell BF, Shekhar A, Nurnberger JI, Steinmetz JE, Hetrick WP. Eyeblink conditioning anomalies in bipolar disorder suggest cerebellar dysfunction. Bipolar Disorders. 11: 19-32. PMID 19133963 DOI: 10.1111/J.1399-5618.2008.00642.X |
0.691 |
|
2008 |
Lowry CA, Hale MW, Evans AK, Heerkens J, Staub DR, Gasser PJ, Shekhar A. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Annals of the New York Academy of Sciences. 1148: 86-94. PMID 19120094 DOI: 10.1196/Annals.1410.004 |
0.331 |
|
2008 |
Carroll CA, Kieffaber PD, Vohs JL, O'Donnell BF, Shekhar A, Hetrick WP. Contributions of spectral frequency analyses to the study of P50 ERP amplitude and suppression in bipolar disorder with or without a history of psychosis. Bipolar Disorders. 10: 776-87. PMID 19032709 DOI: 10.1111/J.1399-5618.2008.00622.X |
0.702 |
|
2008 |
Shekhar A, Potter WZ, Lightfoot J, Lienemann J, Dubé S, Mallinckrodt C, Bymaster FP, McKinzie DL, Felder CC. Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. The American Journal of Psychiatry. 165: 1033-9. PMID 18593778 DOI: 10.1176/Appi.Ajp.2008.06091591 |
0.368 |
|
2008 |
Goddard AW, Shekhar A, Whiteman AF, McDougle CJ. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discovery Today. 13: 325-32. PMID 18405845 DOI: 10.1016/J.Drudis.2007.12.009 |
0.311 |
|
2008 |
Sajdyk T, Johnson P, Fitz S, Shekhar A. Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior. Journal of Psychopharmacology (Oxford, England). 22: 633-41. PMID 18308797 DOI: 10.1177/0269881107082902 |
0.305 |
|
2008 |
Johnson P, Lowry C, Truitt W, Shekhar A. Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic. Journal of Psychopharmacology (Oxford, England). 22: 642-52. PMID 18308791 DOI: 10.1177/0269881107082900 |
0.309 |
|
2008 |
Hayden EP, Bodkins M, Brenner C, Shekhar A, Nurnberger JI, O'Donnell BF, Hetrick WP. A multimethod investigation of the behavioral activation system in bipolar disorder. Journal of Abnormal Psychology. 117: 164-70. PMID 18266494 DOI: 10.1037/0021-843X.117.1.164 |
0.689 |
|
2008 |
Vohs JL, Hetrick WP, Kieffaber PD, Bodkins M, Bismark A, Shekhar A, O'Donnell BF. Visual event-related potentials in schizotypal personality disorder and schizophrenia. Journal of Abnormal Psychology. 117: 119-31. PMID 18266490 DOI: 10.1037/0021-843X.117.1.119 |
0.696 |
|
2008 |
Johannesen JK, Bodkins M, O'Donnell BF, Shekhar A, Hetrick WP. Perceptual anomalies in schizophrenia co-occur with selective impairments in the gamma frequency component of midlatency auditory ERPs. Journal of Abnormal Psychology. 117: 106-18. PMID 18266489 DOI: 10.1037/0021-843X.117.1.106 |
0.694 |
|
2008 |
Carroll CA, Boggs J, O'Donnell BF, Shekhar A, Hetrick WP. Temporal processing dysfunction in schizophrenia. Brain and Cognition. 67: 150-61. PMID 18262701 DOI: 10.1016/J.Bandc.2007.12.005 |
0.7 |
|
2008 |
Edwards CR, Newman S, Bismark A, Skosnik PD, O'Donnell BF, Shekhar A, Steinmetz JE, Hetrick WP. Cerebellum volume and eyeblink conditioning in schizophrenia. Psychiatry Research. 162: 185-94. PMID 18222655 DOI: 10.1016/J.Pscychresns.2007.06.001 |
0.693 |
|
2008 |
Ascher-Svanum H, Nyhuis AW, Faries DE, Kinon BJ, Baker RW, Shekhar A. Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia. Schizophrenia Bulletin. 34: 1163-71. PMID 18156640 DOI: 10.1093/Schbul/Sbm134 |
0.345 |
|
2007 |
Chambers RA, Sajdyk TJ, Conroy SK, Lafuze JE, Fitz SD, Shekhar A. Neonatal amygdala lesions: co-occurring impact on social/fear-related behavior and cocaine sensitization in adult rats. Behavioral Neuroscience. 121: 1316-27. PMID 18085884 DOI: 10.1037/0735-7044.121.6.1316 |
0.313 |
|
2007 |
Kieffaber PD, O'Donnell BF, Shekhar A, Hetrick WP. Event related brain potential evidence for preserved attentional set switching in schizophrenia. Schizophrenia Research. 93: 355-65. PMID 17466490 DOI: 10.1016/J.Schres.2007.03.018 |
0.683 |
|
2007 |
Carroll CA, Vohs JL, O'donnell BF, Shekhar A, Hetrick WP. Sensorimotor gating in manic and mixed episode bipolar disorder. Bipolar Disorders. 9: 221-9. PMID 17430296 DOI: 10.1111/J.1399-5618.2007.00415.X |
0.715 |
|
2007 |
Truitt WA, Sajdyk TJ, Dietrich AD, Oberlin B, McDougle CJ, Shekhar A. From anxiety to autism: spectrum of abnormal social behaviors modeled by progressive disruption of inhibitory neuronal function in the basolateral amygdala in Wistar rats. Psychopharmacology. 191: 107-18. PMID 17277936 DOI: 10.1007/S00213-006-0674-Y |
0.337 |
|
2007 |
Lee Y, Gaskins D, Anand A, Shekhar A. Glia mechanisms in mood regulation: a novel model of mood disorders. Psychopharmacology. 191: 55-65. PMID 17225169 DOI: 10.1007/S00213-006-0652-4 |
0.362 |
|
2007 |
Tohen M, Vieta E, Amsterdam JJ, Aaronson ST, Sun B, Bowden C, Banov M, Shekhar A, Oliff HS, Kryzhanovskaya L. P.2.f.002 Olanzapine versus divalproex and placebo for the treatment of mild to moderate mania associated with bipolar I disorder European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70577-1 |
0.319 |
|
2006 |
O'Donnell BF, Bismark A, Hetrick WP, Bodkins M, Vohs JL, Shekhar A. Early stage vision in schizophrenia and schizotypal personality disorder. Schizophrenia Research. 86: 89-98. PMID 16829048 DOI: 10.1016/J.Schres.2006.05.016 |
0.7 |
|
2006 |
Evans AK, Abrams JK, Bouwknecht JA, Knight DM, Shekhar A, Lowry CA. The anxiogenic drug FG-7142 increases serotonin metabolism in the rat medial prefrontal cortex. Pharmacology, Biochemistry, and Behavior. 84: 266-74. PMID 16784772 DOI: 10.1016/J.Pbb.2006.05.007 |
0.306 |
|
2006 |
Sajdyk TJ, Fitz SD, Shekhar A. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Stress (Amsterdam, Netherlands). 9: 21-8. PMID 16753930 DOI: 10.1080/10253890600557315 |
0.311 |
|
2006 |
Kieffaber PD, Kappenman ES, Bodkins M, Shekhar A, O'Donnell BF, Hetrick WP. Switch and maintenance of task set in schizophrenia. Schizophrenia Research. 84: 345-58. PMID 16563700 DOI: 10.1016/J.Schres.2006.01.022 |
0.682 |
|
2006 |
Spiga F, Lightman SL, Shekhar A, Lowry CA. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons. Neuroscience. 138: 1265-76. PMID 16488545 DOI: 10.1016/J.Neuroscience.2005.12.051 |
0.308 |
|
2005 |
Lowry CA, Johnson PL, Hay-Schmidt A, Mikkelsen J, Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress (Amsterdam, Netherlands). 8: 233-46. PMID 16423712 DOI: 10.1080/10253890500492787 |
0.301 |
|
2005 |
Shekhar A, Truitt W, Rainnie D, Sajdyk T. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress (Amsterdam, Netherlands). 8: 209-19. PMID 16423710 DOI: 10.1080/10253890500504557 |
0.324 |
|
2005 |
Johannesen JK, Kieffaber PD, O'Donnell BF, Shekhar A, Evans JD, Hetrick WP. Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia. Schizophrenia Research. 78: 269-84. PMID 16002265 DOI: 10.1016/J.Schres.2005.05.022 |
0.7 |
|
2005 |
Abrams JK, Johnson PL, Hay-Schmidt A, Mikkelsen JD, Shekhar A, Lowry CA. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience. 133: 983-97. PMID 15916857 DOI: 10.1016/J.Neuroscience.2005.03.025 |
0.309 |
|
2005 |
Brown SM, Kieffaber PD, Carroll CA, Vohs JL, Tracy JA, Shekhar A, O'Donnell BF, Steinmetz JE, Hetrick WP. Eyeblink conditioning deficits indicate timing and cerebellar abnormalities in schizophrenia. Brain and Cognition. 58: 94-108. PMID 15878730 DOI: 10.1016/J.Bandc.2004.09.011 |
0.704 |
|
2005 |
Gehlert DR, Shekhar A, Morin SM, Hipskind PA, Zink C, Gackenheimer SL, Shaw J, Fitz SD, Sajdyk TJ. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. European Journal of Pharmacology. 509: 145-53. PMID 15733549 DOI: 10.1016/J.Ejphar.2004.12.030 |
0.325 |
|
2005 |
Krishnan GP, Vohs JL, Hetrick WP, Carroll CA, Shekhar A, Bockbrader MA, O'Donnell BF. Steady state visual evoked potential abnormalities in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 116: 614-24. PMID 15721075 DOI: 10.1016/J.Clinph.2004.09.016 |
0.675 |
|
2005 |
Ball SG, Kuhn A, Wall D, Shekhar A, Goddard AW. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline. The Journal of Clinical Psychiatry. 66: 94-9. PMID 15669894 DOI: 10.4088/Jcp.V66N0113 |
0.32 |
|
2004 |
Zirnheld PJ, Carroll CA, Kieffaber PD, O'Donnell BF, Shekhar A, Hetrick WP. Haloperidol impairs learning and error-related negativity in humans. Journal of Cognitive Neuroscience. 16: 1098-112. PMID 15298795 DOI: 10.1162/0898929041502779 |
0.658 |
|
2004 |
Koss WA, Gehlert DR, Shekhar A. Different effects of subchronic doses of 17-beta estradiol in two ethologically based models of anxiety utilizing female rats. Hormones and Behavior. 46: 158-64. PMID 15256305 DOI: 10.1016/J.Yhbeh.2004.02.011 |
0.304 |
|
2004 |
O'Donnell BF, Vohs JL, Hetrick WP, Carroll CA, Shekhar A. Auditory event-related potential abnormalities in bipolar disorder and schizophrenia. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 53: 45-55. PMID 15172135 DOI: 10.1016/J.Ijpsycho.2004.02.001 |
0.718 |
|
2004 |
O'Donnell BF, Hetrick WP, Vohs JL, Krishnan GP, Carroll CA, Shekhar A. Neural synchronization deficits to auditory stimulation in bipolar disorder. Neuroreport. 15: 1369-72. PMID 15167568 DOI: 10.1097/01.Wnr.0000127348.64681.B2 |
0.702 |
|
2004 |
Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3471-9. PMID 15071094 DOI: 10.1523/Jneurosci.5740-03.2004 |
0.336 |
|
2004 |
Carroll CA, O'Donnell BF, Shekhar A, Hetrick WP. The effects of olanzapine on sensory gating in healthy participants. Schizophrenia Research. 66: 187-9. PMID 15061253 DOI: 10.1016/S0920-9964(03)00149-X |
0.636 |
|
2003 |
Sajdyk TJ, Keim SR, Thielen SR, Fitz SD, Shekhar A. Measurement of panic-like responses following intravenous infusion of sodium lactate in panic-prone rats. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.17. PMID 18428590 DOI: 10.1002/0471142301.Ns0917S24 |
0.362 |
|
2003 |
Beglinger LJ, Ahmed S, Derby MA, Siemers E, Fastenau PS, Crawford-Miller J, Shekhar A, Kareken DA. Neuropsychological practice effects and change detection in people with schizophrenia. Schizophrenia Research. 62: 191-4. PMID 12765761 DOI: 10.1016/S0920-9964(02)00425-5 |
0.313 |
|
2003 |
Anand A, Shekhar A. Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Annals of the New York Academy of Sciences. 985: 370-88. PMID 12724172 DOI: 10.1111/J.1749-6632.2003.Tb07095.X |
0.342 |
|
2003 |
Shekhar A, Sajdyk TJ, Gehlert DR, Rainnie DG. The amygdala, panic disorder, and cardiovascular responses. Annals of the New York Academy of Sciences. 985: 308-25. PMID 12724167 DOI: 10.1111/J.1749-6632.2003.Tb07090.X |
0.341 |
|
2002 |
Sweeten TL, Posey DJ, Shekhar A, McDougle CJ. The amygdala and related structures in the pathophysiology of autism. Pharmacology, Biochemistry, and Behavior. 71: 449-55. PMID 11830179 DOI: 10.1016/S0091-3057(01)00697-9 |
0.349 |
|
2002 |
Thielen SK, Shekhar A. Amygdala priming results in conditioned place avoidance. Pharmacology, Biochemistry, and Behavior. 71: 401-6. PMID 11830174 DOI: 10.1016/S0091-3057(01)00696-7 |
0.333 |
|
2001 |
Shekhar A, McCann UD, Meaney MJ, Blanchard DC, Davis M, Frey KA, Liberzon I, Overall KL, Shear MK, Tecott LH, Winsky L. Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders. Psychopharmacology. 157: 327-39. PMID 11605091 DOI: 10.1007/S002130100859 |
0.34 |
|
2000 |
Sajdyk TJ, Shekhar A. Sodium lactate elicits anxiety in rats after repeated GABA receptor blockade in the basolateral amygdala. European Journal of Pharmacology. 394: 265-73. PMID 10771292 DOI: 10.1016/S0014-2999(00)00128-X |
0.329 |
|
2000 |
Shekhar A, Keim SR. LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats. Neuropharmacology. 39: 1139-46. PMID 10760357 DOI: 10.1016/S0028-3908(99)00215-4 |
0.328 |
|
1999 |
Shekhar A, Sajdyk TS, Keim SR, Yoder KK, Sanders SK. Role of the basolateral amygdala in panic disorder. Annals of the New York Academy of Sciences. 877: 747-50. PMID 10415697 DOI: 10.1111/J.1749-6632.1999.Tb09315.X |
0.338 |
|
1999 |
Sajdyk TJ, Schober DA, Gehlert DR, Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behavioural Brain Research. 100: 207-15. PMID 10212068 DOI: 10.1016/S0166-4328(98)00132-6 |
0.337 |
|
1997 |
Ball S, Robinson A, Shekhar A, Walsh K. Dissociative symptoms in panic disorder. The Journal of Nervous and Mental Disease. 185: 755-60. PMID 9442187 DOI: 10.1097/00005053-199712000-00006 |
0.357 |
|
1997 |
Shekhar A, Keim SR. The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 9726-35. PMID 9391025 DOI: 10.1523/Jneurosci.17-24-09726.1997 |
0.328 |
|
1997 |
Ball S, Shekhar A. Basilar artery response to hyperventilation in panic disorder. The American Journal of Psychiatry. 154: 1603-4. PMID 9356573 DOI: 10.1176/Ajp.154.11.1603 |
0.316 |
|
1997 |
Sajdyk TJ, Katner JS, Shekhar A. Monoamines in the dorsomedial hypothalamus of rats following exposure to different tests of "anxiety". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 21: 193-209. PMID 9075267 DOI: 10.1016/S0278-5846(96)00138-8 |
0.3 |
|
1996 |
Gould RA, Ball S, Kaspi SP, Otto MW, Pollack MH, Shekhar A, Fava M. Prevalence and correlates of anger attacks: a two site study. Journal of Affective Disorders. 39: 31-8. PMID 8835651 DOI: 10.1016/0165-0327(96)00017-1 |
0.337 |
|
1995 |
Sanders SK, Morzorati SL, Shekhar A. Priming of experimental anxiety by repeated subthreshold GABA blockade in the rat amygdala. Brain Research. 699: 250-9. PMID 8616628 DOI: 10.1016/0006-8993(95)00915-D |
0.319 |
|
1995 |
Ball SG, Buchwald AM, Waddell MT, Shekhar A. Depression and generalized anxiety symptoms in panic disorder. Implications for comorbidity. The Journal of Nervous and Mental Disease. 183: 304-8. PMID 7745384 DOI: 10.1097/00005053-199505000-00005 |
0.32 |
|
1994 |
Shekhar A. Effects of treatment with imipramine and clonazepam on an animal model of panic disorder. Biological Psychiatry. 36: 748-58. PMID 7858071 DOI: 10.1016/0006-3223(94)90086-8 |
0.317 |
|
1993 |
Shekhar A. GABA receptors in the region of the dorsomedial hypothalamus of rats regulate anxiety in the elevated plus-maze test. I. Behavioral measures. Brain Research. 627: 9-16. PMID 8293308 DOI: 10.1016/0006-8993(93)90742-6 |
0.301 |
|
Show low-probability matches. |